Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Stattic (STAT3 Inhibitor V) 是一种 STAT3 抑制剂 (IC50=5.1 μM),选择性地抑制 STAT3 活化、二聚化和核转位。Stattic 具有抗肿瘤活性,可诱导细胞凋亡。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 257 | 现货 | ||
10 mg | ¥ 389 | 现货 | ||
25 mg | ¥ 663 | 现货 | ||
50 mg | ¥ 997 | 现货 | ||
100 mg | ¥ 1,660 | 现货 | ||
200 mg | ¥ 2,470 | 现货 | ||
500 mg | ¥ 3,970 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 389 | 现货 |
产品描述 | Stattic (STAT3 Inhibitor V) is a STAT3 inhibitor (IC50=5.1 μM) that selectively inhibits STAT3 activation, dimerization, and nuclear translocation. Stattic has antitumor activity and induces apoptosis. |
靶点活性 | STAT3:5.1 μM (cell free) |
体外活性 |
方法:人胰腺癌细胞 PANC-1 和 BxPc-3 用 Stattic (1-10 μM) 处理 12-48 h,使用 CCK-8 方法检测细胞活力。 结果:Stattic 以浓度和时间依赖的方式降低 PANC-1 和 BxPc-3 细胞增殖。Stattic 处理 24 h 后对 BxPc-3 和 PANC-1 细胞的 IC50 分别为 3.135-5.296 μM 和 3.835-4.165 μM。[1] 方法:人肝癌细胞 HepG2 用 Stattic (5-20 μM) 处理 1 h,随后用 IL-6 或 IFN-γ刺激,使用 Western Blot 方法检测靶点蛋白表达水平。 结果:Stattic 的预孵育导致 STAT3 Tyr705 的磷酸化选择性降低,而 STAT1 Tyr701 的激活保持不变。[2] |
体内活性 |
方法:为检测体内抗肿瘤活性,将 Stattic (10 mg/kg) 腹腔注射给携带人胰腺癌肿瘤 PANC-1 的 BALB/c nude 小鼠,每天一次,持续四周。 结果:Stattic 通过灭活 STAT3 来抑制裸鼠肿瘤模型中的 PC 生长。[1] 方法:为研究在急性肝损伤中的作用,将 Stattic (5 mg/kg in DMSO:olive oil = 1:19) 单次腹腔注射给 LPS/d-GalN 诱导急性肝损伤的 BALB/c 小鼠。 结果:Stattic 对 LPS/d-GalN 诱导的肝损伤具有保护作用,其保护作用可能与其抗炎和抗凋亡作用有关。[3] |
激酶实验 | The screening was performed at approximately 30C. The specificity of screening hits was validated in analogous assays for binding of the test compounds to the SH2 domains of STAT1, STAT5, and Lck. The final concentration of buffer components used for all FP assays was 10 mM HEPES (pH 7.5), 1 mM EDTA, 0.1% Nonidet P-40, 50 mM NaCl, and 10% DMSO. The absence of dithiothreitol is essential for inhibitory activity. The sequences of the peptides were: STAT3, 5-carboxyfluorescein-GY(PO3H2)LPQTV-NH2; STAT1, 5-carboxyfluorescein-GY(PO3H2)DKPHVL; STAT5, 5-carboxyfluorescein-GY (PO3H2)LVLDKW; and Lck, 5-carboxyfluorescein-GY(PO3H2)EEIP. Peptides were >95% pure. For specificity analysis at 30°C, proteins were used at 150 nM (STAT1, STAT3, and STAT5). For specificity analysis at 37°C, proteins were used at 370 nM (STAT3) or 100 nM (Lck). Proteins were incubated with test compounds in tubes at the indicated temperatures for 60 min prior addition of the respective 5-carboxyfluorescein labeled peptides (final concentration: 10 nM). Analysis of c-Myc/Max and Jun/Jun dimerization and DNA binding at 37°C was performed as described but in the absence of DTT. Before measurement at room temperature, the mixtures were allowed to equilibrate for at least 30 min. Test compounds were used at the indicated concentrations diluted from 20× stock in DMSO. Binding curves and inhibition curves were fitted with SigmaPlot. All competition curves were repeated three times in independent experiments. For the analysis of time dependence of the inhibition, the components were mixed from stock solutions kept at 0C and then incubated at 37C. Aliquots were taken at the indicated time points [1]. |
细胞实验 | MDA-MB-231, MDA-MB-435S, and MDA-MB-453 cells were seeded. at 5 × 10^4 cells in 6-well plates, grown for 24 hr before adding DMSO or Stattic (final DMSO concentration 0.1%) and then incubated with the inhibitor for 24 hr. All cells were collected and resuspended in buffer (0.1% sodium citrate, 0.1% Triton X-100, 20 μM propidium iodide) and incubated for 3 hr before 10^4 cells per sample were analyzed by flow cytometry with a FACSCalibur equipped with a 488 nm laser [1]. |
别名 | STAT3 Inhibitor V |
分子量 | 211.19 |
分子式 | C8H5NO4S |
CAS No. | 19983-44-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 1.1 mg/mL (5 mM)
DMSO: 10.6 mg/mL (50 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / DMSO | 1 mM | 4.7351 mL | 23.6754 mL | 47.3507 mL | 118.3768 mL |
5 mM | 0.947 mL | 4.7351 mL | 9.4701 mL | 23.6754 mL | |
DMSO | 10 mM | 0.4735 mL | 2.3675 mL | 4.7351 mL | 11.8377 mL |
20 mM | 0.2368 mL | 1.1838 mL | 2.3675 mL | 5.9188 mL | |
50 mM | 0.0947 mL | 0.4735 mL | 0.947 mL | 2.3675 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Stattic 19983-44-9 Apoptosis JAK/STAT signaling Stem Cells STAT inhibit Alport PC3M-1E8 cancer p-STAT3 prostate S727 syndrome Inhibitor P-ERK1/2 SH2 STAT3 Inhibitor V S phase Y705 inhibitor